Likelihood of Psych Disorders Lower With Weight-Loss Surgery Versus GLP-1 RAs
By Elana Gotkine HealthDay Reporter
FRIDAY, June 20, 2025 -- People undergoing metabolic and bariatric surgery (MBS) are less likely to develop psychiatric disorders than those treated with glucagon-like peptide-1 receptor agonists (GLP-1 RAs), according to a study presented the annual meeting of the American Society for Metabolic and Bariatric Surgery, held from June 15 to 19 in Washington, D.C.
Abdallah Attia, M.D., from the Tulane University School of Medicine in New Orleans, and colleagues compared the risk for psychiatric disorders among patients treated with GLP-1 RAs (semaglutide, liraglutide, and dulaglutide) versus MBS during a five-year follow-up in a retrospective cohort analysis. Each cohort included 33,600 patients after propensity score matching.
The researchers found that compared with treatment with GLP-1 RAs, MBS was associated with a significantly lower risk for anxiety disorders, substance use disorders, and cognitive deficits (hazard ratios, 0.60, 0.61, and 0.36, respectively). No significant differences were seen for psychotic disorders or posttraumatic stress disorder. No meaningful differences were seen between the groups for rare conditions, including dissociative and impulse-control disorders.
"The data supports embedding psychiatric screening and support within both surgical and medical obesity programs to help reduce the potential mental health burden after treatment," coauthor Shauna Levy, M.D., also from Tulane University School Medicine, said in a statement. "Further investigation is needed, however, to determine why the psychological impact is so different between treatment modalities."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted June 2025
Read this next
Variables Associated With Heart Failure Compared for Men and Women
THURSDAY, Aug. 28, 2025 -- Asthma, depression, anxiety, and hypothyroidism are associated with heart failure with preserved ejection fraction (HFpEF) and heart failure with...
Overweight Status Appears to Reduce Mortality in Seniors Undergoing Elective Surgery
THURSDAY, Aug. 28, 2025 -- Older adults (aged 65 years and older) with overweight who undergo elective surgery have a lower rate of 30-day all-cause mortality compared with those...
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
THURSDAY, Aug. 28, 2025 -- U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.